pSivida plunges on FDA knock-back

Stocks in Perth-based biotech pSivida have halved in value after the United States Food and Drug Administration declined to approve its treatment for back-of-the-eye problems associated with diabetes.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment


6th-Australian Institute of Management WA20,000
7th-Murdoch University17,883
8th↓South Regional TAFE10,835
9th-Central Regional TAFE10,000
10th-Training Course Experts10,000
51 tertiary education & training providers ranked by total number of students in WA